Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Overholser

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 9, 2013
Pharmacokinetic modeling and simulation of procainamide and N-acetylprocainamide in a patient receiving continuous renal replacement therapy: a novel approach to guide renal dose adjustmentsAhmed N Mohamed, Ahmed M Abdelhady, Dustin Spencer, et al.
Cancer Genomics & Proteomics|October 30, 2019
MicroRNA 362-3p Reduces hERG-related Current and Inhibits Breast Cancer Cells ProliferationAbdullah A Assiri, Noha Mourad, Minghai Shao, et al.
Applied Clinical Informatics|November 24, 2016
Iterative Development and Evaluation of a Pharmacogenomic-Guided Clinical Decision Support System for Warfarin DosingBrittany L Melton, Alan J Zillich, Jason Saleem, et al.
International Journal of Cardiology|October 11, 2024
Drug-induced increase in dispersion of ventricular repolarization in patients with heart failure with preserved ejection fractionFatimah Alhurayri, Heather A Jaynes, Brian R Overholser, et al.
Pharmacogenomics|July 25, 2020
Pharmacogenomics of methadone: a narrative review of the literatureSenthil Packiasabapathy, Blessed W Aruldhas, Nicole Horn, et al.
JACC. Clinical Electrophysiology|April 29, 2017
Influence of Oral Progesterone Administration on Drug-Induced QT Interval Lengthening: A Randomized, Double-Blind, Placebo-Controlled Crossover StudyJames E Tisdale, Heather A Jaynes, Brian R Overholser, et al.
JACC. Advances|November 21, 2024
Arrhythmias in Patients With Heart Failure Prescribed Dofetilide or SotalolChien-Yu Huang, Brian R Overholser, Kevin M Sowinski, et al.
Plos One|August 19, 2024
Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fractionChien-Yu Huang, Brian R Overholser, Kevin M Sowinski, et al.
Drug Safety|May 23, 2012
Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the USJames E Tisdale, Heather A Wroblewski, Brian R Overholser, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2014
The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patientsJoseph V Pergolizzi, Larry Ma, David R Foster, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 9, 2013
Pharmacokinetic modeling and simulation of procainamide and N-acetylprocainamide in a patient receiving continuous renal replacement therapy: a novel approach to guide renal dose adjustmentsAhmed N Mohamed, Ahmed M Abdelhady, Dustin Spencer, et al.
Cancer Genomics & Proteomics|October 30, 2019
MicroRNA 362-3p Reduces hERG-related Current and Inhibits Breast Cancer Cells ProliferationAbdullah A Assiri, Noha Mourad, Minghai Shao, et al.
Applied Clinical Informatics|November 24, 2016
Iterative Development and Evaluation of a Pharmacogenomic-Guided Clinical Decision Support System for Warfarin DosingBrittany L Melton, Alan J Zillich, Jason Saleem, et al.
International Journal of Cardiology|October 11, 2024
Drug-induced increase in dispersion of ventricular repolarization in patients with heart failure with preserved ejection fractionFatimah Alhurayri, Heather A Jaynes, Brian R Overholser, et al.
Pharmacogenomics|July 25, 2020
Pharmacogenomics of methadone: a narrative review of the literatureSenthil Packiasabapathy, Blessed W Aruldhas, Nicole Horn, et al.
JACC. Clinical Electrophysiology|April 29, 2017
Influence of Oral Progesterone Administration on Drug-Induced QT Interval Lengthening: A Randomized, Double-Blind, Placebo-Controlled Crossover StudyJames E Tisdale, Heather A Jaynes, Brian R Overholser, et al.
JACC. Advances|November 21, 2024
Arrhythmias in Patients With Heart Failure Prescribed Dofetilide or SotalolChien-Yu Huang, Brian R Overholser, Kevin M Sowinski, et al.
Plos One|August 19, 2024
Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fractionChien-Yu Huang, Brian R Overholser, Kevin M Sowinski, et al.
Drug Safety|May 23, 2012
Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the USJames E Tisdale, Heather A Wroblewski, Brian R Overholser, et al.
Journal of Managed Care & Specialty Pharmacy|April 26, 2014
The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patientsJoseph V Pergolizzi, Larry Ma, David R Foster, et al.
Pageof 6